This approval means Quatrefolic® can now be used to formulate nutritional supplements with daily dosages of up to 400mcg folate, in line with the GB 31601 standards. Additionally, it has been approved for inclusion in solid beverages, expanding its versatility in supporting maternal health.
Essential Benefits of Quatrefolic® for Pregnant and Lactating Women
Quatrefolic® offers a variety of benefits for pregnant and lactating women. As an advanced form of folate, it ensures higher bioavailability, which is crucial for supporting the healthy development of the baby. Folate plays a vital role in reducing the risk of neural tube defects and ensuring the proper formation of the fetal spine and brain. During lactation, it helps maintain the mother’s health and supports the nutrient needs of the infant.
Regulatory Recognition in Maternal Health
Do you need more information about Quatrefolic® or have any outstanding questions? Please do not hesitate to contact us; our expert team will be happy to answer!
Ingredients mentioned
Quatrefolic®
Active ingredients
Folate: An innovative dietary ingredient designed to act as a nutrient in all areas where folic acid and folate supplementation is recommended and allowed.
Reproduction & Women’s
Wellness & Immune
Mobility & Joint
Fertility
Pregnancy
Menopause
Quatrefolic® Fine Powder
- Active ingredients
Folate: Quatrefolic® Fine Powder is the new versatile form of folate, a new physical form with a finer and narrower particle size distribution of the raw material.
- Reproduction & Women’s
- Wellness & Immune
- Mobility & Joint
- Fertility
- Pregnancy
- Menopause
Latest news
- Digestion & Gut
- ibSium®
- News
- May 29, 2025
Natural Probiotic Yeast Support on World Digestive Health Day
Each year on May 29, World Digestive Health Day raises global awareness about the...
- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- May 27, 2025
Infodemiology Offers a Fresh Lens on Nutritional Yeast
Haven’t you ever wondered what consumers think about yeast? Infodemiology, an innovative social media...
- MenaQ7®
- Mobility & Joint
- News
- May 21, 2025
K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading...
